about
Biomedical microelectromechanical systems (BioMEMS): Revolution in drug delivery and analytical techniquesUtilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy DeliveryMicroneedles for intradermal and transdermal drug deliveryDissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccineInteractions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and CancerMicro-scale devices for transdermal drug deliveryMicroneedle-based drug and vaccine delivery via nanoporous microneedle arraysCharacterization of polymeric microneedle arrays for transdermal drug deliveryThe Troy Microneedle: A Rapidly Separating, Dissolving Microneedle Formed by Cyclic Contact and Drying on the Pillar (CCDP)Single-Step Fabrication of Computationally Designed Microneedles by Continuous Liquid Interface ProductionMicroneedle-based vaccinesMicroneedle and mucosal delivery of influenza vaccines.Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays.BioMEMS -Advancing the Frontiers of Medicine.Micro Electromechanical Systems (MEMS) Based Microfluidic Devices for Biomedical Applications.A patchless dissolving microneedle delivery system enabling rapid and efficient transdermal drug delivery.Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding techniqueDesign and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs.Transdermal delivery of proteinsLaser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calciumMicroneedle-based drug delivery systems: microfabrication, drug delivery, and safety.Dissolving polymer microneedle patches for influenza vaccination.Dissolving microneedle patch for transdermal delivery of human growth hormone.Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD)Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points.Hollow microneedles for intradermal injection fabricated by sacrificial micromolding and selective electrodeposition.Collection of analytes from microneedle patches.Analysis of Mechanical Failure of Polymer Microneedles by Axial ForceSeparable arrowhead microneedles.The Effects of Geometry on Skin Penetration and Failure of Polymer Microneedles.Rapidly-dissolvable microneedle patches via a highly scalable and reproducible soft lithography approach.Sodium alginate microneedle arrays mediate the transdermal delivery of bovine serum albumin.Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.Effect of liposomal fluidity on skin permeation of sodium fluorescein entrapped in liposomes.A scalable fabrication process of polymer microneedles.A microneedle patch containing measles vaccine is immunogenic in non-human primates.Protein encapsulation in polymeric microneedles by photolithography.Microneedles for drug and vaccine deliveryA facile system to evaluate in vitro drug release from dissolving microneedle arrays.
P2860
Q26768245-AE75251C-DC0F-4CC1-971E-06C5DB66D1BCQ26786070-91B5006E-046E-4B71-8D4B-1DA8093FB994Q26995148-56DAF00F-9C3E-4008-8B45-CE839E292C10Q27013822-958D4F98-105F-4943-BA76-EE6595910E57Q27021261-707A10FA-F4D1-4C7A-9967-F482DD929D3AQ27489779-81FE482D-D479-49B4-82E2-541452090BF5Q28085656-C65F57B7-4843-4C4F-96CB-0523CBA3607FQ28534599-5D91300C-A371-4817-901C-28A17C329383Q28547494-FC5575D2-3F4A-4A81-8359-782F1A7AC0D6Q28553947-3B86C3EF-4F63-45EB-8CD3-EB5C49A25FEFQ30380910-D0319E89-706F-475A-A18D-E3B203A63C5BQ30418015-6D8290F9-12DC-4CEF-AAE4-9DE352E2DA1CQ30426851-8BF0CD6E-0238-49C7-BACE-4A26241F4CD4Q30452558-509A867D-9A09-4189-9714-8D16A08B6072Q30474857-93425520-9E88-4DB8-B311-0C3FA73535C6Q30616801-AE0212A9-25A7-41C9-9937-AE166132B02AQ33583706-8B1309EA-7FC9-4F91-A405-AF52926DAF7EQ33665062-4F39C6D3-89C9-4662-A2EB-B71F306FB737Q33835912-C9890796-7698-4C28-B969-84E24E15115CQ33856010-1FFD15A4-5239-4BFC-A7E7-537D9F1828BCQ33994211-A32ED30E-E89A-4A43-991C-F442EEBAC7F4Q34005731-E19A0F1C-A09C-4ADB-B490-60CFCC404C88Q34049972-6009CD7B-DD45-4730-962E-9049E10F6C59Q34083733-E8D798B7-C24A-4C5A-8EF0-AB5308B84FF9Q34209790-6F5FA749-3628-4590-8ADE-AD5D943AD368Q34402718-1887BCFF-CFF1-4AED-AB06-61A4F39C6F5BQ34439999-09582562-709D-4788-A8D9-124F60F85879Q34464350-8936308C-A89D-44D9-B118-33615ACF2A62Q34467157-CA8F52CC-CC6E-4DF7-BBE4-90C3CCC4B8B7Q34579384-92BC7B15-86B4-4A45-8DC0-4FCBC5D06840Q34642922-71D5EA5F-5F79-4E80-A327-B31B2793B6F4Q34671534-40D981F6-2221-4404-A158-136DB83511EEQ34723050-CEF14FF6-3EEF-4F08-9918-7AF9EFBA35BCQ35132732-CA61E99A-B15F-45BC-85FB-679F02E03ED8Q35729101-310C1EA7-5B9F-4DEB-9D54-B05A3608707FQ35846829-4D8F851D-1350-4823-BFF3-7364A4974640Q36011315-CF09E472-721C-45BF-A287-B12D1BBF806CQ36083214-85F4B660-1F9B-40FF-8827-E1CB0958CF3BQ36164749-F33ECE66-CEE1-4E1F-920E-BAA661590561Q36490572-5459438F-94D5-4140-A727-3C7CB56EBF6A
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Dissolving microneedles for transdermal drug delivery
@ast
Dissolving microneedles for transdermal drug delivery
@en
type
label
Dissolving microneedles for transdermal drug delivery
@ast
Dissolving microneedles for transdermal drug delivery
@en
prefLabel
Dissolving microneedles for transdermal drug delivery
@ast
Dissolving microneedles for transdermal drug delivery
@en
P2093
P2860
P1433
P1476
Dissolving microneedles for transdermal drug delivery
@en
P2093
Jeong W Lee
Jung-Hwan Park
Mark R Prausnitz
P2860
P304
P356
10.1016/J.BIOMATERIALS.2007.12.048
P577
2008-02-07T00:00:00Z